FDA clears blood test to aid evaluation for Alzheimer's disease
The blood-based biomarker test is based on technology developed at WashU Medicine by Randall Bateman, MD, and David Holtzman, MD.
Summary
A new blood test, developed by researchers at Washington University, has received FDA approval to assist in the evaluation of Alzheimer’s disease. This innovative biomarker test could enhance early diagnosis and treatment options for patients.
Comments (90 of ) ⌛